06:11 EDT Lucid Diagnostics (LUCD) files to sell 36.98M shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LUCD:
- Lucid Diagnostics Reports Increased Losses Amid Revenue Decline
- Anticipated Medicare Coverage and Strategic Positioning Drive Buy Rating for Lucid Diagnostics
- Lucid Diagnostics: Strong Cash Position and Growing EsoGuard Test Volumes Justify Buy Rating
- Lucid Diagnostics Reports Q1 2025 Financial Results
- Lucid Diagnostics reports Q1 adjusted EPS (16c), consensus (10c)